ARTICLE SUMMARY:
SpineGuard’s novel screw placement technology is getting warm reviews from surgeons, but a lukewarm reception from investors. How can the company drive its enterprise value? By riding on surgery’s most compelling technology story: robotics.
For a long time, most innovation in medical devices was incremental—second generation technology and tools designed to further or enhance an earlier innovation. Companies and their investors were well-rewarded for those incremental advances with strong adoption and premium prices.
